INNOVATIVE FEDERAL STRATEGIES, LLC for CERUS CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
HR.2810/S.___, National Defense Authorization Act, 2018, any title, all provisions relating to blood products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARL KIME | — |
| KALI MATALON | — |
| NEELY MARCUS SILBEY New | — |
| ANNE MARGARET WAKE New | — |
| LETITIA WHITE | — |
Health Issues HCR
Submitted outside witness testimony on Biomedical Advanced Research and Development Authority.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARL KIME | — |
| KALI MATALON | — |
| NEELY MARCUS SILBEY New | — |
| ANNE MARGARET WAKE New | — |
| LETITIA WHITE | — |
Budget/Appropriations BUD
H.R.___/S.___, Department of Defense Appropriations Act, 2018, Title II, all provisions relating to blood products, Title VI, all provisions related to blood products and technologies. H.R.___/S.___, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2018, Title II, all provisions related to blood products. H.R___/S/___, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018, Title II, all provisions relating to blood products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID FREDERICK KILIAN | — |
| CARL KIME | — |
| KALI MATALON | — |
| NEELY MARCUS SILBEY New | — |
| ANNE MARGARET WAKE New | — |
| LETITIA WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.